AACR22 Preview 1 – Key topics to watch out for

Hot topics to follow at AACR22

March 7, 2022

Finding achilles heels to tackle cancer head on

Exploring new approaches to targeting cancer

January 20, 2022

Can we predict response to breast cancer therapy?

What can we learn from various breast cancer trials?

December 8, 2021

Coming back full circle

Can a genomic signature help select patients more accurately for DDR therapies?

August 26, 2021

Gritting it out

What are Gritstone up to behind the scenes and where are they headed in the near-term?

July 20, 2021

Digging deep with RNA therapeutics

Can AI and deep learning help us re-program genetic defects with RNA therapies?

July 15, 2021

The interface of science, innovation, and imagination

What can deep learning techniques tell us about NASH, Parkinson's, Alzheimer's or even cancer?

July 13, 2021

Are AI and machine learning alive or dead in oncology?

How can AI and ML speed up or improve our drug discovery efforts in oncology R&D?

June 15, 2021

When PARP and immunotherapy worlds collide

New research is emerging which may have an impact on future trial designs as well as combination partners and even different tumour types.

May 12, 2021

How will AI impact oncology R&D?

Some intriguing convergence from two recent conferences offers new insights from an AI perspective

January 28, 2021

Notes from a small island

new approaches to applying translational research to the clinic in oncology R&D

November 3, 2020